Soma is a prescribed muscle relaxant. It is meant to be used short term up "soma drug class change" two or three weeks to treat muscle spasms due to injury or other muscle problems. It is not a controlled substance.

Change soma drug class

Carisoprodol brand name Soma is a skeletal muscle relaxant approved by the FDA for use in painful musculoskeletal conditions on an acute basis. When the mg strength dosage was approved 53 years ago, the class change was classified as a non-controlled, non-scheduled drug. However, on December 12, class change DEA ruled under the CSA that all Carisoprodol products are to be reclassified as schedule IV, "class change" substances as of January 12, due to the high potential for abuse and addictive qualities.

The addictive properties of this medication are due to "class change" body metabolizing it into Meprobamate a schedule IV, controlled substance. Carisoprodol was also found to accelerate the affects of other drugs, such as Hydrocodone and Codeine, resulting in greater soma drug class change potential among users. Schedule I drugs are considered highly addictive with no medicinal purpose, whereas a schedule V drug has a relatively low potential for abuse and is recognized for its accepted medicinal use.

Prior to the DEA ruling, several states had already taken it upon themselves to classify Carisoprodol as ambien with other drugs schedule IV, controlled substance at the state level due to its addictive properties. Consequently, the reclassification of this drug to a does valium go into breast milk substance on the federal level is not surprising.

As a controlled substance, prescriptions for Carisoprodol will now have restrictions on the length of time the prescription remains valid and on liquid xanax essential oil doterra number of class change allowed during this time frame. Previously, a prescription was valid for one year from the date it class change drug soma written with no limitation on the number of refills.

If only 4 refills are used in 6 months the prescription is no longer valid and the patient would not be change to obtain the remaining two refills. This could result in double the number of office visits required for the patient to maintain use of this medication which in turn produces increased costs to insurance carriers. Lorazepam makes me more anxious those prescribers with a valid DEA license authorizing them to write for controlled substances will be allowed to write prescriptions for Carisoprodol.

As a result of this change, the industry may see a decrease in the number of prescriptions written for Carisoprodol and an increase in those written for its alternatives such as Tizanidine, Cyclobenzaprine, Metaxalone, Methocarbamol, and Baclofen, which are not controlled substances. If this occurs, insurance carriers could see an increase in prescription costs depending on which alternative medication is prescribed.

If an injured individual is soma drug to either of these medications, prescription costs could increase significantly. As a soma drug class in providing solutions for cost containment, we understand that these changes could greatly impact prescription drug costs in claims. This site uses Akismet to reduce spam. Learn how your comment data is processed.

Leave a Reply Cancel reply. Sorry, your blog cannot share posts by email.